Researchers at Oregon Health & Science University have developed the first transgenic nonhuman primate model—genetically ...

The discovery opens up opportunities to study the therapeutic properties of ibogaine and related compounds. Ibogaine, a ...

Norovirus is highly infectious and causing a lot of illness this winter. Several vaccine candidates are making their way through clinical trials.

Q1 2025 Earnings Conference Call February 13, 2025 8:00 AM ETCompany ParticipantsSam Fisch - Executive Director, Investor ...

Over the past two decades, the idea of targeting transcription factors to combat malignancies has turned into a clinical reality.

NEW YORK, NY, USA I 13, 2025 I Accropeutics Inc. (Accropeutics), a clinical-stage biotechnology company pioneering the development of novel ...

Scientists created ibogaine synthetically, avoiding plant sourcing. This breakthrough supports addiction research and safer ...

Discover seven companies operating in metabolomics, the field that could significantly boost precision medicine.

Partner Content As the technology industry continues its shift towards AI dominance, an important schism is opening up that ...

As the technology industry continues its shift towards AI dominance, an important schism is opening up that threatens to ...

Sutro Biopharma, Inc. (NASDAQ:STRO – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the eight brokerages that are covering the company, Marketbeat reports. One analyst ...

Q4 2024 Earnings Call Transcript February 11, 2025 Arvinas, Inc. beats earnings expectations. Reported EPS is $-0.63, ...